Specialty Pharmacy

Continuous low-dose cisplatin through an implantable device could be a therapeutic option in for patients with ovarian cancer.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses trends in specialty drug cost management.

Top news of the day from across the health care landscape.

Metastatic urothelial carcinoma drug among key approvals from May 2017.

Statins also found to play key role in preventing cardiovascular events.

Rheumatoid arthritis drug among key FDA drug approvals from last month.

Top news of the week in oncology and cancer drug development.

As chemotherapy resistance builds, cancer cells develop a new Achilles’ heel.

The Centers for Medicare & Medicaid Services seeks to improve accuracy of data reported from direct and indirect remuneration fees.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

HIV-positive individuals are twice as likely to die of smoking than the disease.

Immune checkpoint inhibitors have revolutioned cancer treatment, but not all patients respond to immunotherapy.

Biosimilar programs seeks to increase accessibility to expensive medications.

Scientists found that some breast cancer patients have a co-occurrence of genetic mutations.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Wider access to new direct-acting antivirals for people who inject drugs may help reduce HCV infections.

Kevin Mange, MD, MSCE, head of North America Medical Immunology at Sanofi, provides a comprehensive overview of the considerations in the treatment of rheumatoid arthritis, which carries comorbidities that affect multiple organ systems.

The IL-17 inhibitor reduced the number of tender and swollen joints in at least 20% of patients with PsA.

Immunotherapies have improved survival in cancer patients.

While incidences of metastatic breast cancer are increasing, so is survival.

Scientists redesigned a portion of rituximab into a new molecule to treat amyotrophic lateral sclerosis.

A compound in aged cheese, mushrooms, and whole grains found to increase life span by 25% in animal models.

Top news of the day from across the health care landscape.

Cheryl Allen, vice president of Industry Relations at Diplomat Specialty Pharmacy, discusses the elements of an effective, high touch patient care program.

Patients with HIV can now expect to live into old age, and therefore need links to the community health network.

Isentress HD is a once daily treatment for HIV-1 that helps patients achieve viral suppression.

GLUT1 inhibitors could be a potential therapeutic target for the squamous subtype of cancer.

Society for Integrative Oncology releases updated clinical guidelines on integrative breast cancer treatments.

Tocilizumab (Actemra) is the first drug approved to treat giant cell arteritis.